At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers ; volume:22 ; number:1 ; day:9 ; month:5 ; year:2022 ; pages:1-10 ; date:12.2022
BMC infectious diseases ; 22, Heft 1 (9.5.2022), 1-10, 12.2022
- Creator
-
Humphreys, Devon P.
Gavin, Kathleen M.
Olds, Kaylan M.
Bonaca, Marc P.
Bauer, Timothy A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-022-07377-4
- URN
-
urn:nbn:de:101:1-2022071607103386637709
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Humphreys, Devon P.
- Gavin, Kathleen M.
- Olds, Kaylan M.
- Bonaca, Marc P.
- Bauer, Timothy A.
- SpringerLink (Online service)
Other Objects (12)
Duration of SARS-CoV-2 viral RNA in asymptomatic carriers
Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission
SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission
Molecular analysis of hepatitis B virus "a" determinant in asymptomatic and symptomatic Mexican carriers
Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients
Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers
HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
A comparison between asymptomatic and symptomatic ureteral stones
Asymptomatic and Pre-Symptomatic COVID-19 in China
Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis
Performance of SARS-CoV-2 antigen testing in symptomatic and asymptomatic adults: a single-center evaluation
Duration of SARS-CoV-2 viral RNA in asymptomatic carriers
Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission
SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission
Molecular analysis of hepatitis B virus "a" determinant in asymptomatic and symptomatic Mexican carriers
Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients
Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers
HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
A comparison between asymptomatic and symptomatic ureteral stones
Asymptomatic and Pre-Symptomatic COVID-19 in China
Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis
Performance of SARS-CoV-2 antigen testing in symptomatic and asymptomatic adults: a single-center evaluation
Duration of SARS-CoV-2 viral RNA in asymptomatic carriers
Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission
SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission
Molecular analysis of hepatitis B virus "a" determinant in asymptomatic and symptomatic Mexican carriers
Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients
Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers
HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
A comparison between asymptomatic and symptomatic ureteral stones
Asymptomatic and Pre-Symptomatic COVID-19 in China
Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis